| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Hematology/Oncology, University Children's Hospital, and Division of Molecular Oncology, German Cancer Research Center, Im Neuenheimer Feld 150, D-69120 Heidelberg, Germany
Anticancer agents have been shown to trigger apoptosis in chemosensitive tumors such as neuroblastomas. We previously identified activation of the CD95 system as one of the key mechanisms for doxorubicin-induced apoptosis in leukemic T cells. Here, we report that therapeutic concentrations of doxorubicin, cisplatinum, and VP-16 led to induction of CD95 receptor and CD95 ligand (CD95-L) that mediated cell death in chemosensitive neuroblastoma cells. Using F(ab')2 anti-CD95 antibody fragments to interfere with CD95-L-receptor interaction markedly reduced apoptosis induced by those drugs in vitro. Cyclosporin A inhibited induction of CD95 mRNA and CD95-L mRNA and blocked drug-mediated apoptosis. Drug-induced apoptosis involved activation of caspases (interleukin 1ß-converting enzyme/Ced-3-like proteases) and processing of the prototype caspase substrate PARP and was completely blocked by benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone, a peptide inhibitor of caspases. In addition, neuroblastoma cells that were resistant to CD95-triggered apoptosis also displayed cross-resistance to chemotherapeutic agents. These data provide new clues for understanding the molecular requirements for drug-induced apoptosis in chemosensitive neuroblastoma cells by demonstrating that cell death was mediated via the CD95-L-receptor system and may open new avenues for targeting drugresistance of neuroblastoma.
1 This work was supported by grants from the Deutsche Forschungsgemeinschaft (to K-M. D.), the Tumor Center Heidelberg/Mannheim, and the Deutsche Leukämieforschungshilfe.
2 Current address and to whom requests for reprints should be addressed, at University Children's Hospital, Prittwitzstrasse 43, D-89075 Ulm, Germany. Phone: 49-731 502 7700; Fax: 49-731 502 6681.
Received 3/24/97. Accepted 7/ 3/97.
This article has been cited by other articles:
![]() |
M. Vogler, H. Walczak, D. Stadel, T. L. Haas, F. Genze, M. Jovanovic, U. Bhanot, C. Hasel, P. Moller, J. E. Gschwend, et al. Small Molecule XIAP Inhibitors Enhance TRAIL-Induced Apoptosis and Antitumor Activity in Preclinical Models of Pancreatic Carcinoma Cancer Res., March 15, 2009; 69(6): 2425 - 2434. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vogler, H. Walczak, D. Stadel, T. L. Haas, F. Genze, M. Jovanovic, J. E. Gschwend, T. Simmet, K.-M. Debatin, and S. Fulda Targeting XIAP Bypasses Bcl-2-Mediated Resistance to TRAIL and Cooperates with TRAIL to Suppress Pancreatic Cancer Growth In vitro and In vivo Cancer Res., October 1, 2008; 68(19): 7956 - 7965. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Opel, M.-A. Westhoff, A. Bender, V. Braun, K.-M. Debatin, and S. Fulda Phosphatidylinositol 3-Kinase Inhibition Broadly Sensitizes Glioblastoma Cells to Death Receptor- and Drug-Induced Apoptosis Cancer Res., August 1, 2008; 68(15): 6271 - 6280. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Accordi, S. Pillozzi, M. C. Dell'Orto, G. Cazzaniga, A. Arcangeli, G. t. Kronnie, and G. Basso Hepatocyte Growth Factor Receptor c-MET Is Associated with FAS and When Activated Enhances Drug-induced Apoptosis in Pediatric B Acute Lymphoblastic Leukemia with TEL-AML1 Translocation J. Biol. Chem., October 5, 2007; 282(40): 29384 - 29393. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Razzaque Cisplatin nephropathy: is cytotoxicity avoidable? Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2112 - 2116. [Full Text] [PDF] |
||||
![]() |
J. d. S. Correia, Y. Miranda, N. Leonard, and R. J. Ulevitch The Subunit CSN6 of the COP9 Signalosome Is Cleaved during Apoptosis J. Biol. Chem., April 27, 2007; 282(17): 12557 - 12565. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fulda, C. Poremba, B. Berwanger, S. Hacker, M. Eilers, H. Christiansen, B. Hero, and K.-M. Debatin Loss of Caspase-8 Expression Does Not Correlate with MYCN Amplification, Aggressive Disease, or Prognosis in Neuroblastoma. Cancer Res., October 15, 2006; 66(20): 10016 - 10023. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Darnowski, F. A. Goulette, Y.-j. Guan, D. Chatterjee, Z.-F. Yang, L. P. Cousens, and Y. E. Chin Stat3 Cleavage by Caspases: IMPACT ON FULL-LENGTH Stat3 EXPRESSION, FRAGMENT FORMATION, AND TRANSCRIPTIONAL ACTIVITY J. Biol. Chem., June 30, 2006; 281(26): 17707 - 17717. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Haluska, J. M. Carboni, D. A. Loegering, F. Y. Lee, M. Wittman, M. G. Saulnier, D. B. Frennesson, K. R. Kalli, C. A. Conover, R. M. Attar, et al. In vitro and In vivo Antitumor Effects of the Dual Insulin-Like Growth Factor-I/Insulin Receptor Inhibitor, BMS-554417 Cancer Res., January 1, 2006; 66(1): 362 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gaiddon, P. Jeannequin, P. Bischoff, M. Pfeffer, C. Sirlin, and J. P. Loeffler Ruthenium (II)-Derived Organometallic Compounds Induce Cytostatic and Cytotoxic Effects on Mammalian Cancer Cell Lines through p53-Dependent and p53-Independent Mechanisms J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1403 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Lavoie, L. LeSauteur, J. Kohn, J. Wong, O. Furtoss, C. J. Thiele, F. D. Miller, and D. R. Kaplan TrkA Induces Apoptosis of Neuroblastoma Cells and Does So via a p53-dependent Mechanism J. Biol. Chem., August 12, 2005; 280(32): 29199 - 29207. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Kim, L. Liu, S.-O. Lee, Y.-T. Kim, K.-R. You, and D.-G. Kim Susceptibility of Cholangiocarcinoma Cells to Parthenolide-Induced Apoptosis Cancer Res., July 15, 2005; 65(14): 6312 - 6320. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baldi, D. Lombardi, P. Russo, E. Palescandolo, A. De Luca, D. Santini, F. Baldi, L. Rossiello, M. L. Dell'Anna, A. Mastrofrancesco, et al. Ferritin Contributes to Melanoma Progression by Modulating Cell Growth and Sensitivity to Oxidative Stress Clin. Cancer Res., May 1, 2005; 11(9): 3175 - 3183. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Terrasson, S. Allart, H. Martin, J. Lule, H. Haddada, D. Caput, and C. Davrinche p73-Dependent Apoptosis through Death Receptor: Impairment by Human Cytomegalovirus Infection Cancer Res., April 1, 2005; 65(7): 2787 - 2794. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Hussein Apoptosis in the ovary: molecular mechanisms Hum. Reprod. Update, March 1, 2005; 11(2): 162 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Ozvaran, X. X. Cao, S. D. Miller, B. A. Monia, W. K. Hong, and W. R. Smythe Antisense oligonucleotides directed at the bcl-xl gene product augment chemotherapy response in mesothelioma Mol. Cancer Ther., May 1, 2004; 3(5): 545 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yang and F. G. Haluska Treatment of Melanoma with 5-Fluorouracil or Dacarbazine In Vitro Sensitizes Cells to Antigen-Specific CTL Lysis through Perforin/Granzyme- and Fas-Mediated Pathways J. Immunol., April 1, 2004; 172(7): 4599 - 4608. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Bian, T. D. Giordano, H.-J. Lin, G. Solomon, V. P. Castle, and A. W. Opipari Jr. Chemotherapy-induced Apoptosis of S-type Neuroblastoma Cells Requires Caspase-9 and Is Augmented by CD95/Fas Stimulation J. Biol. Chem., February 6, 2004; 279(6): 4663 - 4669. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pingoud-Meier, D. Lang, A. J. Janss, L. B. Rorke, P. C. Phillips, T. Shalaby, and M. A. Grotzer Loss of Caspase-8 Protein Expression Correlates with Unfavorable Survival Outcome in Childhood Medulloblastoma Clin. Cancer Res., December 15, 2003; 9(17): 6401 - 6409. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wu, M. A. McKenna, X. Feng, T. R. Nagy, and J. M. McDonald Osteoclast Apoptosis: The Role of Fas in Vivo and in Vitro Endocrinology, December 1, 2003; 144(12): 5545 - 5555. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Wittke, R. Wiedemeyer, A. Pillmann, L. Savelyeva, F. Westermann, and M. Schwab Neuroblastoma-Derived Sulfhydryl Oxidase, a New Member of the Sulfhydryl Oxidase/Quiescin6 Family, Regulates Sensitization to Interferon {gamma}-Induced Cell Death in Human Neuroblastoma Cells Cancer Res., November 15, 2003; 63(22): 7742 - 7752. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Delmas, C. Rebe, S. Lacour, R. Filomenko, A. Athias, P. Gambert, M. Cherkaoui-Malki, B. Jannin, L. Dubrez-Daloz, N. Latruffe, et al. Resveratrol-induced Apoptosis Is Associated with Fas Redistribution in the Rafts and the Formation of a Death-inducing Signaling Complex in Colon Cancer Cells J. Biol. Chem., October 17, 2003; 278(42): 41482 - 41490. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hueber, M. Weller, G. Welsandt, N. Kociok, B. Kirchhof, and P. Esser Characterization of Daunorubicin-Induced Apoptosis in Retinal Pigment Epithelial Cells: Modulation by CD95L Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 2851 - 2857. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Harada, S. Toyooka, N. Shivapurkar, A. Maitra, J. L. Reddy, H. Matta, K. Miyajima, C. F. Timmons, G. E. Tomlinson, D. Mastrangelo, et al. Deregulation of Caspase 8 and 10 Expression in Pediatric Tumors and Cell Lines Cancer Res., October 15, 2002; 62(20): 5897 - 5901. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Huigsloot, I. B. Tijdens, G. J. Mulder, and B. van de Water Differential Regulation of Doxorubicin-induced Mitochondrial Dysfunction and Apoptosis by Bcl-2 in Mammary Adenocarcinoma (MTLn3) Cells J. Biol. Chem., September 20, 2002; 277(39): 35869 - 35879. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Greene, J. Thorburn, M. C. Willingham, A. Thorburn, R. P. Planalp, M. W. Brechbiel, J. Jennings-Gee, J. Wilkinson IV, F. M. Torti, and S. V. Torti Activation of Caspase Pathways during Iron Chelator-mediated Apoptosis J. Biol. Chem., July 5, 2002; 277(28): 25568 - 25575. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cui, A. Schroering, and H.-F. Ding p53 Mediates DNA Damaging Drug-induced Apoptosis through a Caspase-9-dependent Pathway in SH-SY5Y Neuroblastoma Cells Mol. Cancer Ther., July 1, 2002; 1(9): 679 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Avivi-Green, S. Polak-Charcon, Z. Madar, and B. Schwartz Different Molecular Events Account for Butyrate-Induced Apoptosis in Two Human Colon Cancer Cell Lines J. Nutr., July 1, 2002; 132(7): 1812 - 1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Charrier, A. Jarry, C. Toquet, C. Bou-Hanna, M. Chedorge, M. Denis, G. Vallette, and C. L. Laboisse Growth Phase-dependent Expression of ICAD-L/DFF45 Modulates the Pattern of Apoptosis in Human Colonic Cancer Cells Cancer Res., April 1, 2002; 62(7): 2169 - 2174. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Park, M. De Leon, and P. Devarajan Cisplatin Induces Apoptosis in LLC-PK1 Cells via Activation of Mitochondrial Pathways J. Am. Soc. Nephrol., April 1, 2002; 13(4): 858 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lorenzo, C. Ruiz-Ruiz, A. J. Quesada, G. Hernandez, A. Rodriguez, A. Lopez-Rivas, and J. M. Redondo Doxorubicin Induces Apoptosis and CD95 Gene Expression in Human Primary Endothelial Cells through a p53-dependent Mechanism J. Biol. Chem., March 22, 2002; 277(13): 10883 - 10892. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ochs, J. Lips, S. Profittlich, and B. Kaina Deficiency in DNA Polymerase {beta} Provokes Replication-dependent Apoptosis via DNA Breakage, Bcl-2 Decline and Caspase-3/9 Activation Cancer Res., March 1, 2002; 62(5): 1524 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. de Thonel, A. Bettaieb, C. Jean, G. Laurent, and A. Quillet-Mary Role of protein kinase C zeta isoform in Fas resistance of immature myeloid KG1a leukemic cells Blood, December 15, 2001; 98(13): 3770 - 3777. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Stahnke, S. Fulda, C. Friesen, G. Strau{beta}, and K.-M. Debatin Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy Blood, November 15, 2001; 98(10): 3066 - 3073. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Herr and K.-M. Debatin Cellular stress response and apoptosis in cancer therapy Blood, November 1, 2001; 98(9): 2603 - 2614. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Jones, K. Ganeshaguru, A. E. Virchis, N. I. Folarin, M. W. Lowdell, A. B. Mehta, H. G. Prentice, A. V. Hoffbrand, and R. G. Wickremasinghe Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation Blood, November 1, 2001; 98(9): 2800 - 2807. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chatterjee, I. Schmitz, A. Krueger, K. Yeung, S. Kirchhoff, P. H. Krammer, M. E. Peter, J. H. Wyche, and P. Pantazis Induction of Apoptosis in 9-Nitrocamptothecin-treated DU145 Human Prostate Carcinoma Cells Correlates with de Novo Synthesis of CD95 and CD95 Ligand and Down-Regulation of c-FLIPshort Cancer Res., October 1, 2001; 61(19): 7148 - 7154. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Laurent and J.-P. Jaffrezou Signaling pathways activated by daunorubicin Blood, August 15, 2001; 98(4): 913 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Poulaki, N. Mitsiades, M. E. Romero, and M. Tsokos Fas-mediated Apoptosis in Neuroblastoma Requires Mitochondrial Activation and Is Inhibited by FLICE Inhibitor Protein and bcl-2 Cancer Res., June 1, 2001; 61(12): 4864 - 4872. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Frost, L. H. Butterfield, V. B. Dissette, J. S. Economou, and B. Bonavida Immunosensitization of Melanoma Tumor Cells to Non-MHC Fas-Mediated Killing by MART-1-Specific CTL Cultures J. Immunol., March 1, 2001; 166(5): 3564 - 3573. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Eggert, M. A. Grotzer, T. J. Zuzak, B. R. Wiewrodt, R. Ho, N. Ikegaki, and G. M. Brodeur Resistance to Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis in Neuroblastoma Cells Correlates with a Loss of Caspase-8 Expression Cancer Res., February 1, 2001; 61(4): 1314 - 1319. [Abstract] [Full Text] |
||||
![]() |
S. Mandlekar, V. Hebbar, K. Christov, and A-N. T. Kong Pharmacodynamics of Tamoxifen and Its 4-Hydroxy and N-Desmethyl Metabolites: Activation of Caspases and Induction of Apoptosis in Rat Mammary Tumors and in Human Breast Cancer Cell Lines Cancer Res., December 1, 2000; 60(23): 6601 - 6606. [Abstract] [Full Text] |
||||
![]() |
C. G. Ferreira, S. W. Span, G. J. Peters, F. A. E. Kruyt, and G. Giaccone Chemotherapy Triggers Apoptosis in a Caspase-8-dependent and Mitochondria-controlled Manner in the Non-Small Cell Lung Cancer Cell Line NCI-H460 Cancer Res., December 1, 2000; 60(24): 7133 - 7141. [Abstract] [Full Text] |
||||
![]() |
S.-Y. Sun, P. Yue, W. K. Hong, and R. Lotan Induction of Fas Expression and Augmentation of Fas/Fas Ligand-mediated Apoptosis by the Synthetic Retinoid CD437 in Human Lung Cancer Cells Cancer Res., November 15, 2000; 60(22): 6537 - 6543. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-T. Jan, B.-H. Chen, S.-H. Ma, C.-I Liu, H.-P. Tsai, H.-C. Wu, S.-Y. Jiang, K.-D. Yang, and M.-F. Shaio Potential Dengue Virus-Triggered Apoptotic Pathway in Human Neuroblastoma Cells: Arachidonic Acid, Superoxide Anion, and NF-kappa B Are Sequentially Involved J. Virol., September 15, 2000; 74(18): 8680 - 8691. [Abstract] [Full Text] |
||||
![]() |
T. Nakamura, Y. Ueda, Y. Juan, S. Katsuda, H. Takahashi, and E. Koh Fas-Mediated Apoptosis in Adriamycin-Induced Cardiomyopathy in Rats : In Vivo Study Circulation, August 1, 2000; 102(5): 572 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Petak, D. M. Tillman, F. G. Harwood, R. Mihalik, and J. A. Houghton Fas-dependent and -independent Mechanisms of Cell Death following DNA Damage in Human Colon Carcinoma Cells Cancer Res., May 1, 2000; 60(10): 2643 - 2650. [Abstract] [Full Text] |
||||
![]() |
T. L. Weigel, M. T. Lotze, P. K. Kim, A. A. Amoscato, J. D. Luketich, and C. Odoux PACLITAXEL-INDUCED APOPTOSIS IN NON-SMALL CELL LUNG CANCER CELL LINES IS ASSOCIATED WITH INCREASED CASPASE-3 ACTIVITY J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 795 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Ferreira, C. Tolis, S. W. Span, G. J. Peters, T. van Lopik, A. J. Kummer, H. M. Pinedo, and G. Giaccone Drug-induced Apoptosis in Lung Cancer Cells Is Not Mediated by the Fas/FasL (CD95/APO1) Signaling Pathway Clin. Cancer Res., January 1, 2000; 6(1): 203 - 212. [Abstract] [Full Text] |
||||
![]() |
P. A. Svingen, A. Tefferi, T. J. Kottke, G. Kaur, V. L. Narayanan, E. A. Sausville, and S. H. Kaufmann Effects of the bcr/abl Kinase Inhibitors AG957 and NSC 680410 on Chronic Myelogenous Leukemia Cells in Vitro Clin. Cancer Res., January 1, 2000; 6(1): 237 - 249. [Abstract] [Full Text] |
||||
![]() |
S. Fulda, G. Strauss, E. Meyer, and K.-M. Debatin Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells Blood, January 1, 2000; 95(1): 301 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Cuvillier, E. Mayhew, A. S. Janoff, and S. Spiegel Liposomal ET-18-OCH3 Induces Cytochrome c-Mediated Apoptosis Independently of CD95 (APO-1/Fas) Signaling Blood, November 15, 1999; 94(10): 3583 - 3592. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Ariza, M. Broome-Powell, J. M. Lahti, V. J. Kidd, and M. A. Nelson Fas-induced Apoptosis in Human Malignant Melanoma Cell Lines Is Associated with the Activation of the p34cdc2-related PITSLRE Protein Kinases J. Biol. Chem., October 1, 1999; 274(40): 28505 - 28513. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Glick, S. L. Swendeman, D. C. Coffey, R. A. Rifkind, P. A. Marks, V. M. Richon, and M. P. La Quaglia Hybrid Polar Histone Deacetylase Inhibitor Induces Apoptosis and CD95/CD95 Ligand Expression in Human Neuroblastoma Cancer Res., September 1, 1999; 59(17): 4392 - 4399. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Beltinger, S. Fulda, T. Kammertoens, E. Meyer, W. Uckert, and K.-M. Debatin Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases PNAS, July 20, 1999; 96(15): 8699 - 8704. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Srivastava, C. Y. Sasaki, J. M. Hardwick, and D. L. Longo Bcl-2-Mediated Drug Resistance: Inhibition of Apoptosis by Blocking Nuclear Factor of Activated T Lymphocytes (Nfat)-Induced FAS Ligand Transcription J. Exp. Med., July 19, 1999; 190(2): 253 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Velier, J. A. Ellison, K. K. Kikly, P. A. Spera, F. C. Barone, and G. Z. Feuerstein Caspase-8 and Caspase-3 Are Expressed by Different Populations of Cortical Neurons Undergoing Delayed Cell Death after Focal Stroke in the Rat J. Neurosci., July 15, 1999; 19(14): 5932 - 5941. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Maris and K. K. Matthay Molecular Biology of Neuroblastoma J. Clin. Oncol., July 1, 1999; 17(7): 2264 - 2264. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Landowski, K. H. Shain, M. M. Oshiro, I. Buyuksal, J. S. Painter, and W. S. Dalton Myeloma Cells Selected for Resistance to CD95-Mediated Apoptosis Are Not Cross-Resistant to Cytotoxic Drugs: Evidence for Independent Mechanisms of Caspase Activation Blood, July 1, 1999; 94(1): 265 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bantel, I. H. Engels, W. Voelter, K. Schulze-Osthoff, and S. Wesselborg Mistletoe Lectin Activates Caspase-8/FLICE Independently of Death Receptor Signaling and Enhances Anticancer Drug-induced Apoptosis Cancer Res., May 1, 1999; 59(9): 2083 - 2090. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wesselborg, I. H. Engels, E. Rossmann, M. Los, and K. Schulze-Osthoff Anticancer Drugs Induce Caspase-8/FLICE Activation and Apoptosis in the Absence of CD95 Receptor/Ligand Interaction Blood, May 1, 1999; 93(9): 3053 - 3063. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tang, J. M. Lahti, J. Grenet, and V. J. Kidd Cycloheximide-induced T-cell Death Is Mediated by a Fas-associated Death Domain-dependent Mechanism J. Biol. Chem., March 12, 1999; 274(11): 7245 - 7252. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Mo and W. T. Beck DNA Damage Signals Induction of Fas Ligand in Tumor Cells Mol. Pharmacol., February 1, 1999; 55(2): 216 - 222. [Abstract] [Full Text] |
||||
![]() |
S. Fulda, C. Scaffidi, S. A. Susin, P. H. Krammer, G. Kroemer, M. E. Peter, and K.-M. Debatin Activation of Mitochondria and Release of Mitochondrial Apoptogenic Factors by Betulinic Acid J. Biol. Chem., December 18, 1998; 273(51): 33942 - 33948. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muller, S. Wilder, D. Bannasch, D. Israeli, K. Lehlbach, M. Li-Weber, S. L. Friedman, P. R. Galle, W. Stremmel, M. Oren, et al. p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs J. Exp. Med., December 7, 1998; 188(11): 2033 - 2045. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Evan and T. Littlewood A Matter of Life and Cell Death Science, August 28, 1998; 281(5381): 1317 - 1322. [Abstract] [Full Text] |
||||
![]() |
M.-V. Clement, J. L. Hirpara, S.-H. Chawdhury, and S. Pervaiz Chemopreventive Agent Resveratrol, a Natural Product Derived From Grapes, Triggers CD95 Signaling-Dependent Apoptosis in Human Tumor Cells Blood, August 1, 1998; 92(3): 996 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Jeremias, C. Kupatt, B. Baumann, I. Herr, T. Wirth, and K.M. Debatin Inhibition of Nuclear Factor kappa B Activation Attenuates Apoptosis Resistance in Lymphoid Cells Blood, June 15, 1998; 91(12): 4624 - 4631. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cervellera, G. Raschella, G. Santilli, B. Tanno, A. Ventura, C. Mancini, C. Sevignani, B. Calabretta, and A. Sala Direct Transactivation of the Anti-apoptotic Gene Apolipoprotein J (Clusterin) by B-MYB J. Biol. Chem., July 7, 2000; 275(28): 21055 - 21060. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, J. L. Martindale, and N. J. Holbrook Requirement for ERK Activation in Cisplatin-induced Apoptosis J. Biol. Chem., December 8, 2000; 275(50): 39435 - 39443. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Li, T. Kondo, Q.-L. Zhao, F.-J. Li, K. Tanabe, Y. Arai, Z.-C. Zhou, and M. Kasuya Apoptosis Induced by Cadmium in Human Lymphoma U937 Cells through Ca2+-calpain and Caspase-Mitochondria- dependent Pathways J. Biol. Chem., December 8, 2000; 275(50): 39702 - 39709. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Leo, Q. L. Deveraux, C. Buchholtz, K. Welsh, S.-i. Matsuzawa, H. R. Stennicke, G. S. Salvesen, and J. C. Reed TRAF1 Is a Substrate of Caspases Activated during Tumor Necrosis Factor Receptor-alpha -induced Apoptosis J. Biol. Chem., March 9, 2001; 276(11): 8087 - 8093. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Bian, L. M. McAllister-Lucas, F. Shao, K. R. Schumacher, Z. Feng, A. G. Porter, V. P. Castle, and A. W. Opipari Jr. NF-kappa B Activation Mediates Doxorubicin-induced Cell Death in N-type Neuroblastoma Cells J. Biol. Chem., December 21, 2001; 276(52): 48921 - 48929. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |